Ilham M Alshiraihi

3PUBLICATIONS
2CO-AUTHORS
Nanotoxicology, health and safetyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 04, 2021
Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic.

Ilham M Alshiraihi, Gerald L Klein, Mark A Brown

|Dec 18, 2020
In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells.

Ilham M Alshiraihi, Dillon K Jarrell, Zeyad Arhouma

|Jul 30, 2020
The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo.

Melissa A Edwards, Mark A Brown, Ilham Alshiraihi

Pageof 1